Sheffield Teaching Hospitals NHS Foundation Trust
287 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Haematology Department, Laboratory Medicine Centre (North Lane), North General Hospital, Herries Road
Sheffield S5 7AU , United Kingdom
Sheffield S5 7AU , United Kingdom
Accreditation
Active
UKAS
8508
nhs.net
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8508
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield
Sheffield Teaching Hospitals NHS Foundation Trust
Western Bank
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield
Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield
Sheffield Teaching Hospitals NHS Foundation Trust
Western Bank
Sheffield Teaching Hospitals NHS Foundation Trust
Doncaster
Test Capabilities (287)
| Standard Reference | Description | Category |
|---|---|---|
| Cortisol | Cortisol | Chromatography (GC, HPLC) |
| Sirolimus | Sirolimus | Chromatography (GC, HPLC) |
| % Recovery Prolactin | % Recovery Prolactin | Clinical Chemistry |
| 17 Hydroxy Progesterone | Blood | 17-hydroxy progesterone | Clinical Chemistry |
| 24h Volume (mL) by weight measurement | 24h Volume (mL) by weight measurement | Clinical Chemistry |
| 24hr Urine Creatinine | Urine | 24hr Urine Creatinine | Clinical Chemistry |
| 24hr Urine 5HIAA | Urine | 24hr Urine 5HIAA | Clinical Chemistry |
| 24hr Urine Adrenaline | Urine | 24hr Urine Adrenaline | Clinical Chemistry |
| 24hr Urine Calcium | Urine | 24hr Urine Calcium | Clinical Chemistry |
| 24hr Urine Chloride | Urine | 24hr Urine Chloride | Clinical Chemistry |
| 24hr Urine Copper | Urine | 24hr Urine Copper | Clinical Chemistry |
| 24hr Urine Dopamine | Urine | 24hr Urine Dopamine | Clinical Chemistry |
| 24hr Urine Magnesium | Urine | 24hr Urine Magnesium | Clinical Chemistry |
| 24hr Urine Metanephrines | Urine | 24hr Urine Metanephrines | Clinical Chemistry |
| 24hr Urine Microalbumin | Urine | 24hr Urine Microalbumin | Clinical Chemistry |
| 24hr Urine NTX/Creatinine ratio | 24hr Urine NTX/Creatinine ratio | Clinical Chemistry |
| 24hr Urine Noradrenaline | Urine | 24hr Urine Noradrenaline | Clinical Chemistry |
| 24hr Urine Normetanephrines | Urine | 24hr Urine Normetanephrines | Clinical Chemistry |
| 24hr Urine Potassium | Urine | 24hr Urine Potassium | Clinical Chemistry |
| 24hr Urine Sodium | Urine | 24hr Urine Sodium | Clinical Chemistry |
| 24hur Urine Phosphate | Urine | 24hur Urine Phosphate | Clinical Chemistry |
| 24hur Urine Protein | Urine | 24hur Urine Protein | Clinical Chemistry |
| 24hur Urine Urea measurement | 24hur Urine Urea measurement | Clinical Chemistry |
| 24hur Urine Uric Acid | Urine | 24hur Urine Uric Acid | Clinical Chemistry |
| 5HIAA | Urine | 5HIAA | Clinical Chemistry |
| ALT | ALT | Clinical Chemistry |
| AST | AST | Clinical Chemistry |
| Albumin | Albumin | Clinical Chemistry |
| Alpha 2 Antiplasmin | Alpha 2-Antiplasmin | Clinical Chemistry |
| Amylase Creatinine ratio | Amylase Creatinine ratio | Clinical Chemistry |
| Amylase/Creatinine Clearance ratio | Amylase/Creatinine Clearance ratio | Clinical Chemistry |
| Androstenedione measurement | Androstenedione measurement | Clinical Chemistry |
| Angiotensin Converting | Angiotensin Converting | Clinical Chemistry |
| Anion Gap | Anion Gap | Clinical Chemistry |
| Antithrombin Antigen | Antithrombin-Antigen | Clinical Chemistry |
| Bile Acids | Bile acids | Clinical Chemistry |
| Biochemistry examination activities for the purpose of clinical diagnosis | Biochemistry examination activities for the purpose of clinical diagnosis: Metabolic biochemistry | Clinical Chemistry |
| C Reactive Protein | C-Reactive Protein | Clinical Chemistry |
| C-Peptide | C-Peptide | Clinical Chemistry |
| Calcium | Calcium | Clinical Chemistry |
| Calcium Excretion | Calcium Excretion | Clinical Chemistry |
| Carbamazepine | Carbamazepine | Clinical Chemistry |
| Carboxyhaemoglobin measurement | Carboxyhaemoglobin measurement | Clinical Chemistry |
| Catecholamines | Catecholamines | Clinical Chemistry |
| Cholesterol | Cholesterol : HDL cholesterol ratio | SOP: CS-LAB-CHE-PRO-67 | Clinical Chemistry |
| Corrected Calcium | Corrected Calcium | Clinical Chemistry |
| Creatinine (Enzymatic) | Creatinine (Enzymatic) | Clinical Chemistry |
| Creatinine (Jaffe) | Creatinine (Jaffe) | Clinical Chemistry |
| Creatinine Clearance | Creatinine Clearance | Clinical Chemistry |
| Creatinine Kinase | Creatinine Kinase | Clinical Chemistry |
| Direct Bilirubin | Direct Bilirubin | Clinical Chemistry |
| Drugs of abuse screening | Drugs of abuse screening: Cocaine | Clinical Chemistry |
| FSH | FSH | Clinical Chemistry |
| FSH/LH Ratio | FSH/LH Ratio | Clinical Chemistry |
| Fibrinogen Antigen | Fibrinogen Antigen | Clinical Chemistry |
| Folate | Folate | Clinical Chemistry |
| Fondaparinux | Fondaparinux | Clinical Chemistry |
| Fractional Excretion of Calcium | Fractional Excretion of Calcium | Clinical Chemistry |
| Free Androgen Index | Free Androgen Index | Clinical Chemistry |
| Gamma GT | gamma-GT | Clinical Chemistry |
| Gentamicin | Gentamicin | Clinical Chemistry |
| Globulin | Globulin | Clinical Chemistry |
| IGF 1 | IgF-1 | Clinical Chemistry |
| Insulin | Insulin | Clinical Chemistry |
| LDH | LDH | Clinical Chemistry |
| LDL Cholesterol | LDL-Cholesterol | Clinical Chemistry |
| Lactate | Lactate | Clinical Chemistry |
| Lamotrigine | Lamotrigine | Clinical Chemistry |
| Lead | Lead | Clinical Chemistry |
| Metanephrines | Metanephrines | Clinical Chemistry |
| Non HDL Cholesterol | Non-HDL Cholesterol | Clinical Chemistry |
| Osmolal Gap | Osmolal Gap | Clinical Chemistry |
| Osmolality | Osmolality | Clinical Chemistry |
| Phenobarbital | Phenobarbital | Clinical Chemistry |
| Phenytoin | Phenytoin | Clinical Chemistry |
| Phosphate | Phosphate | Clinical Chemistry |
| Prolactin | Prolactin | Clinical Chemistry |
| Renal Phosphate Threshold | Renal Phosphate Threshold | Clinical Chemistry |
| SMV NTX/CR Ratio | SMV NTX/CR Ratio | Clinical Chemistry |
| Salicylate | Salicylate | Clinical Chemistry |
| Selenium | Selenium | Clinical Chemistry |
| Tacrolimus | Tacrolimus | Clinical Chemistry |
| Teicoplanin measurement | Teicoplanin measurement | Clinical Chemistry |
| Theophylline | Theophylline | Clinical Chemistry |
| Tobramycin | Tobramycin | Clinical Chemistry |
| Total Cholesterol/HDL Ratio | Total Cholesterol/HDL Ratio | Clinical Chemistry |
| Triglyceride | Triglyceride | Clinical Chemistry |
| UREA | Urea | Clinical Chemistry |
| URIC Acid | Uric acid | Clinical Chemistry |
| Urea Clearance | Urea Clearance | Clinical Chemistry |
| Uric Acid measurement | Uric Acid measurement | Clinical Chemistry |
| Urine Adrenaline / Creatinine ratio | Urine Adrenaline / Creatinine ratio | Clinical Chemistry |
| Urine Copper/Creatinine Ratio | Urine Copper/Creatinine Ratio | Clinical Chemistry |
| Urine Creatinine (Mass) | Urine Creatinine (Mass) | Clinical Chemistry |
| Urine Dopamine / Creatinine ratio | Urine Dopamine / Creatinine ratio | Clinical Chemistry |
| Urine Mercury/Creat Ratio | Urine Mercury/Creat Ratio | Clinical Chemistry |
| Urine Microalbumin Ratio | Urine Microalbumin Ratio | Clinical Chemistry |
| Urine Noradrenaline / Creatinine ratio | Urine Noradrenaline / Creatinine ratio | Clinical Chemistry |
| Urine PBG/Creatinine ratio | Urine PBG/Creatinine ratio | Clinical Chemistry |
| Urine Protein/Creatinine Ratio | Urine Protein/Creatinine Ratio | Clinical Chemistry |
| Urine Urea (Mass) | Urine Urea (Mass) | Clinical Chemistry |
| Urine lead/creat ratio eGFR EPI | Urine lead/creat ratio eGFR EPI | Clinical Chemistry |
| Valproate | Valproate | Clinical Chemistry |
| Vancomycin | Vancomycin | Clinical Chemistry |
| Zinc | Zinc | Clinical Chemistry |
| MEASUREMENT | Measurement | Electrical |
| Chloride | Chloride | Elemental Analysis |
| Potassium | Potassium | Elemental Analysis |
| Sodium | Sodium | Elemental Analysis |
| MICROALBUMIN | Microalbumin | Food Safety Testing |
| APTT +50% correction | APTT +50% correction | Hematology |
| APTT ratio | APTT ratio | Hematology |
| Automated coagulation screen tests: Prothrombin time INR | Automated coagulation screen tests: Prothrombin time INR | Hematology |
| Basophil Count | Basophil Count | Hematology |
| Bethesda inhibitor measurement | Bethesda inhibitor measurement | Hematology |
| Blood Transfusion examinations for the purposes of clinical diagnosis | Blood Transfusion examinations for the purposes of clinical diagnosis | Hematology |
| Blood film assessment for the detection of abnormal cell types, morphology and numbers measurement | Blood film assessment for the detection of abnormal cell types, morphology and numbers measurement | Hematology |
| Blood group (ABO and Rh D type) | Blood group (ABO and Rh D type) | Hematology |
| CD34 enumeration, measuring absolute number of haemopoietic stem cells | CD34 enumeration, measuring absolute number of haemopoietic stem cells | Hematology |
| Cell Haemoglobin | Cell Haemoglobin | Hematology |
| Confirmation of haemoglobin variants | Confirmation of haemoglobin variants | Hematology |
| Count Platelet Count | Count Platelet Count | Hematology |
| Count Red Blood | Count Red Blood | Hematology |
| D-Dimer Reptilase time | D-Dimer Reptilase time | Hematology |
| Detection of abnormal haemoglobin* (HbA2 and HbF) and putative identification of Hb variants | Detection of abnormal haemoglobin* (HbA2 and HbF) and putative identification of Hb variants | Hematology |
| Determination of blood group (ABO and RhD type) | Determination of blood group (ABO and RhD type) | Hematology |
| Direct IIa inhibitors | Direct IIa inhibitors | Hematology |
| Direct Xa Inhibitors: HAE-LP HAE 024 Rivaroxaban HAE-LP-HAE-026 Apixaban HAE-LP-HAE-027 Endoxaban | Direct Xa Inhibitors: HAE-LP HAE 024 Rivaroxaban HAE-LP-HAE-026 Apixaban HAE-LP-HAE-027 Endoxaban | Hematology |
| ESR measurement | ESR measurement | Hematology |
| Eosinophil Count | Eosinophil Count | Hematology |
| Fibrinogen (Clauss & derived) | Fibrinogen (Clauss & derived) | Hematology |
| Free Protein S | Free Protein S | Hematology |
| Full Blood Count | Full Blood Count: White blood cells, neutrophils, lymphocytes, eosinophils, monocytes, basophils, nucleated red blood cells, reticulocytes | Hematology |
| G6PD Screen | Whole Blood - EDTA | Biotech G6PD screen | Hematology |
| G6PD assay | G6PD assay | Hematology |
| Haematocrit | Haematocrit | Hematology |
| Haematology examinations for the purposes of clinical diagnosis | Haematology examinations for the purposes of clinical diagnosis | Hematology |
| Haemoglobin | Haemoglobin | Hematology |
| Haemoglobin Mean | Haemoglobin Mean | Hematology |
| Hb S, C, D- Punjab, E, O- Arab, Lepore | Hb S, C, D- Punjab, E, O- Arab, Lepore | Hematology |
| Heparinoid | Heparinoid | Hematology |
| Identification of any haemoglobin variant | Identification of any haemoglobin variant | Hematology |
| Lymphocyte Count | Lymphocyte Count | Hematology |
| Mean Cell | Mean Cell | Hematology |
| Mean Cell Volume | Mean cell volume | Hematology |
| Monocyte Count | Monocyte Count | Hematology |
| Neutrophil Count | Neutrophil Count | Hematology |
| Nucleated Red Cells | Nucleated Red Cells | Hematology |
| PT +50% correction APTT | PT +50% correction APTT | Hematology |
| Quantification of Haemoglobin | Quantification of haemoglobin | Hematology |
| Quantification of HbA1c measurement | Quantification of HbA1c measurement | Hematology |
| Quantitative assay of non- specific clotting factor inhibitors | Quantitative assay of non- specific clotting factor inhibitors | Hematology |
| Quantitative determination of total glycated haemoglobin | Quantitative determination of total glycated haemoglobin | Hematology |
| Quantitative measurement of ADAMTS-13 Activity | Quantitative measurement of ADAMTS-13 Activity | Hematology |
| Quantitative measurement of Antithrombin Antigen | Quantitative measurement of Antithrombin Antigen | Hematology |
| Quantitative measurement of Factor VII antigen | Quantitative measurement of Factor VII antigen | Hematology |
| Quantitative measurement of Factor X antigen | Quantitative measurement of Factor X antigen | Hematology |
| Quantitative measurement of Plasma Viscosity | Quantitative measurement of Plasma Viscosity | Hematology |
| Quantitative measurement of Protein C antigen | Quantitative measurement of Protein C antigen | Hematology |
| Quantitative measurement of VWF antigen | Quantitative measurement of VWF antigen | Hematology |
| Quantitative measurement of Von Willebrand Factor Activity | Quantitative measurement of Von Willebrand Factor Activity | Hematology |
| Quantitative measurement of Von Willebrand Factor Antigen | Quantitative measurement of Von Willebrand Factor Antigen | Hematology |
| Quantitative measurement of protein C antigen measurement | Quantitative measurement of protein C antigen measurement | Hematology |
| Quantitative measurement of the following anticoagulants: Low molecular weight heparin | Quantitative measurement of the following anticoagulants: Low molecular weight heparin | Hematology |
| Quantitative measurement of the following clotting factor inhibitors: Quantitative assay of VIII | Quantitative measurement of the following clotting factor inhibitors: Quantitative assay of VIII | Hematology |
| Reticulocyte Count | Reticulocyte count | Hematology |
| Screen for Sickle | Screen for Sickle | Hematology |
| Thrombin Time | Thrombin Time | Hematology |
| Thrombin time and Protamine | Thrombin time and Protamine | Hematology |
| Unfractionated heparin | Unfractionated heparin | Hematology |
| White Blood Cell | White Blood Cell | Hematology |
| Willebrand Factor inhibitor assay | Willebrand Factor inhibitor assay | Hematology |
| Bone marrow morphological examination: assessment for detection of abnormal cell types, morphology and numbers | Bone marrow morphological examination: assessment for detection of abnormal cell types, morphology and numbers | Histopathology / Cytology |
| Anti-B-2-Glycoprotein-1 | Anti-B-2-Glycoprotein-1 | Immunology / Serology |
| Anti-β-2-Glycoprotein-1 IgM | Anti-β-2-Glycoprotein-1 IgM | Immunology / Serology |
| Antibody identification of red cell antibodies to: C, D, E, c, e,Cw,M,N,S,s,P1,Lua, K, k, Kpa, Lea,Leb,Fya,Fyb,Jka, Jkb | Antibody identification of red cell antibodies to: C, D, E, c, e,Cw,M,N,S,s,P1,Lua, K, k, Kpa, Lea,Leb,Fya,Fyb,Jka, Jkb | Immunology / Serology |
| Antibody screening for red cell antibodies to: C, D, E, c, e, M, N, S, s, P1, K, k, Lea, Leb, Fya, Fyb, Jka, Jkb | Antibody screening for red cell antibodies to: C, D, E, c, e, M, N, S, s, P1, K, k, Lea, Leb, Fya, Fyb, Jka, Jkb | Immunology / Serology |
| Direct Antiglobulin Test including anti-IgG and anti- C3d | Direct Antiglobulin Test including anti-IgG and anti- C3d | Immunology / Serology |
| Growth Hormone | Growth Hormone | Immunology / Serology |
| Immunophenotyping examinations for the purposes of clinical diagnosis Techniques as described below: Acute leukaemia panel to identify immunophenotype of leukaemic blast cells, to assess cell lineage, maturation stage, prognostic markers, and diagnose type of haematological malignancy using the following antibodies CD3, CD7, CD10, CD13, CD14, CD15, CD16, CD19, CD20 CD25, CD33, CD34, CD38, CD45, CD117, HLADR, CD64, CD2, Cytoplasmic MPO, CD22, CD3, CD79a and TDT, CD4, CD5, CD8, CD56, CD1A, CD26, CD11c CD11b, CD41, CD61, CD235a | Immunophenotyping examinations for the purposes of clinical diagnosis Techniques as described below: Lymphocyte subset analysis, percentage and absolute number of: CD3, CD3/4, CD3/8, CD19, CD16/56, CD4/CD8 ratio | Immunology / Serology |
| Isoenzymes hCG | Isoenzymes hCG | Immunology / Serology |
| Lymphoproliferative Panel | Lymphoproliferative panel: For identification of leukaemic lymphoid cells to assess maturation stage, possible prognostic markers, and sub- classify type of leukaemia/ lymphoma/myeloma using antibodies CD19, CD20, CD10, FMC7, CD23, CD79b, CD3, CD5, CD200, CD43, CD103, CD11C, CD25, Kappa, Lambda, CD1A, CD2, CD7, CD26, CD4, CD8, HLADR, CD56, CD16, CD138, CD38, Cytoplasmic CD3, CD79a, CD22, and TDT measurement | Immunology / Serology |
| Mononucleosis heterophile antibody | Mononucleosis heterophile antibody | Immunology / Serology |
| Parathyroid Hormone | Parathyroid Hormone | Immunology / Serology |
| Quantitative measurement of the following: Anti-Cardiolipin IgG and IgM antibodies | Quantitative measurement of the following: Anti-Cardiolipin IgG and IgM antibodies | Immunology / Serology |
| Allele mutation (p20210a) measurement | Allele mutation (p20210a) measurement | Molecular Diagnostics / PCR |
| Detection of Factor V Leiden (FVL) mutation | Detection of Factor V Leiden (FVL) mutation | Molecular Diagnostics / PCR |
| Detection of Prothrombin | Detection of Prothrombin | Molecular Diagnostics / PCR |
| ADAMITS13 activity | ADAMITS13 activity | Other |
| ADAMTS 13 activity | ADAMTS-13 Activity | Other |
| Activity | Activity | Other |
| Amylase | Amylase | Other |
| Anti Mullerian Hormone | Anti-Mullerian Hormone | Other |
| Assessment of iron (Haemosiderin) and detection of ringed sideroblasts in bone marrow smears measurement | Assessment of iron (Haemosiderin) and detection of ringed sideroblasts in bone marrow smears measurement | Other |
| Barbitruate | Barbitruate | Other |
| Barbiturates | Barbiturates | Other |
| Calculated Tests for the purposes of clinical diagnosis: % Saturation IBC | Calculated Tests for the purposes of clinical diagnosis: % Saturation IBC | Other |
| Cannabinoid | Cannabinoid | Other |
| Capacity | Capacity | Other |
| Chromogenic FIX activity determination and Refixia (N9- GP) monitoring | Chromogenic FIX activity determination and Refixia (N9- GP) monitoring | Other |
| Chromogenic FVIII- determination of FVIII level relative to FX activation measurement | Chromogenic FVIII- determination of FVIII level relative to FX activation measurement | Other |
| Chromogenic Protein C | Chromogenic Protein C | Other |
| Clone size reported as a % | Clone size reported as a % | Other |
| Clotting Protein C Activity | Clotting Protein C Activity | Other |
| Clotting Protein S | Clotting Protein S | Other |
| Coagulation examinations for the purposes of clinical diagnosis | Coagulation examinations for the purposes of clinical diagnosis | Other |
| Concentration | Concentration | Other |
| Cyclizine | Cyclizine | Other |
| DHEAS hCG | DHEAS hCG | Other |
| Detection and quantitation of malarial parasites | Detection and quantitation of malarial parasites; | Other |
| Detection of Infectious | Detection of Infectious | Other |
| Detection of whole blood haemostasis measurement | Detection of whole blood haemostasis measurement | Other |
| Digoxin high sensitivity Troponin T | Digoxin high sensitivity Troponin T | Other |
| Dilute Russell Viper Venom | Dilute Russell Viper Venom | Other |
| Enzyme measurement | Enzyme measurement | Other |
| Ethylene Glycol | Ethylene glycol | Other |
| FXIII Assay | FXIII Assay | Other |
| Factor V Leiden screen | Factor V Leiden screen | Other |
| Fluoxetine measurement | Fluoxetine measurement | Other |
| Hb in maternal blood for FMH determination measurement | Hb in maternal blood for FMH determination measurement | Other |
| Heparin induced thrombocytopenia screen for the detection of associated IgG antibody | Heparin induced thrombocytopenia screen for the detection of associated IgG antibody | Other |
| High molecular weight kininogen and prekallikrein | High molecular weight kininogen and prekallikrein | Other |
| Immuno platelet counting utilising CD61, CD41 and CD42b to determine the platelet count | Immuno platelet counting utilising CD61, CD41 and CD42b to determine the platelet count | Other |
| Kleihauer-Screen for Foetal | Kleihauer-Screen for Foetal | Other |
| LH | LH | Other |
| Lipoprotein A measurement | Lipoprotein A measurement | Other |
| Manual coagulation tests as follows: PT APTT | Manual coagulation tests as follows: PT APTT | Other |
| Neonatal group and direct antiglobulin test | Neonatal group and direct antiglobulin test | Other |
| P1NP nt-ProBNP | P1NP nt-ProBNP | Other |
| Phenotyping | Phenotyping | Other |
| Placental groth factor (PIGF) | Placental groth factor (PIGF) | Other |
| Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, Plasmodium knowlesi | Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, Plasmodium knowlesi | Other |
| Platelet glycoprotein analysis using CD61, CD41 and CD42b to determine normal, reduced or absent antigen expression | Platelet glycoprotein analysis using CD61, CD41 and CD42b to determine normal, reduced or absent antigen expression | Other |
| Procyclidine measurement | Procyclidine measurement | Other |
| Progressive Antithrombin | Progressive Antithrombin | Other |
| Protein | Protein | Other |
| Qualitative detection of heparin binding site defects in antithrombin | Qualitative detection of heparin binding site defects in antithrombin | Other |
| Qualitative measurement FVIII binding | Qualitative measurement FVIII binding | Other |
| Quantitative assay of Von | Quantitative assay of Von | Other |
| Quantitative measurement of ADAMTS-13 Antibody | Quantitative measurement of ADAMTS-13 Antibody | Other |
| Quantitative measurement of FXIII antigen | Quantitative measurement of FXIII antigen | Other |
| Quantitative measurement of Total and Free Protein | Quantitative measurement of Total and Free Protein | Other |
| Quantitative measurement of collagen binding of vWF | Quantitative measurement of collagen binding of vWF | Other |
| Quantitative measurement of the following clotting factor levels: Chromogenic FIX- determination of FIX level relative to FX activation | Quantitative measurement of the following clotting factor levels: Factor II, V, VII, VIII, IX, X, XI, XII | Other |
| Quantitative measurement of the following for diagnosis of thrombophilia: Chromogenic Antithrombin (IIa and Xa) | Quantitative measurement of the following for diagnosis of thrombophilia: Chromogenic Antithrombin (IIa and Xa) | Other |
| Screen and high resolution assay for demonstration of paroxysmal nocturnal haemoglobinuria | Screen and high resolution assay for demonstration of paroxysmal nocturnal haemoglobinuria | Other |
| Screen and quantitation of Foetal Hb in maternal blood for FMH determination measurement | Screen and quantitation of Foetal Hb in maternal blood for FMH determination measurement | Other |
| Screening and confirmation of the drugs of abuse: Amphetamine Benzodiazepine Cocaine and metabolites Gabapentin Ketamine Methadone and metabolites Noscapine Opiates Oxycodone Pregabalin Tramadol Buprenorphine and metabolites | Screening and confirmation of the drugs of abuse: Amphetamine Benzodiazepine Cocaine and metabolites Gabapentin Ketamine Methadone and metabolites Noscapine Opiates Oxycodone Pregabalin Tramadol Buprenorphine and metabolites | Other |
| Serological cross match or electronic issue | Serological cross match or electronic issue | Other |
| Soluble fms-like tyrosine kinase-1 (sFlt) sFlt/PIGF ratio | Soluble fms-like tyrosine kinase-1 (sFlt) sFlt/PIGF ratio | Other |
| Sulphate Correction | Sulphate Correction | Other |
| Testosterone measurement | Testosterone measurement | Other |
| Thrombin time Fibrinogen | Thrombin time Fibrinogen | Other |
| Time | Time | Other |
| Titration of Anti-A and Anti B | Titration of Anti-A and Anti B | Other |
| Total Iron Binding Capacity | Total Iron Binding Capacity | Other |
| Trazodone | Trazodone | Other |
| Two stage Factor VIII, an incubation step for production of FXa and second step to determine the amount of FXa proportional to FVIII level | Two stage Factor VIII, an incubation step for production of FXa and second step to determine the amount of FXa proportional to FVIII level | Other |
| Unsaturated Iron Binding | Unsaturated Iron Binding | Other |
| VWF multimers | VWF multimers | Other |
| Vitamin D | Vitamin D | Other |
| ACTH | ACTH | Spectroscopy (XRF, ICP, AAS) |
| AMMONIA | Ammonia | Spectroscopy (XRF, ICP, AAS) |
| Alkaline Phosphatase | Alkaline Phosphatase | Spectroscopy (XRF, ICP, AAS) |
| Aluminium | Aluminium | Spectroscopy (XRF, ICP, AAS) |
| Beta HCG | Beta-HCG | Spectroscopy (XRF, ICP, AAS) |
| Bicarbonate | Bicarbonate | Spectroscopy (XRF, ICP, AAS) |
| Bilirubin | Bilirubin | Spectroscopy (XRF, ICP, AAS) |
| Ciclosporin | Ciclosporin | Spectroscopy (XRF, ICP, AAS) |
| Copper | Copper | Spectroscopy (XRF, ICP, AAS) |
| Ethanol | Ethanol | Spectroscopy (XRF, ICP, AAS) |
| Ferritin | Ferritin | Spectroscopy (XRF, ICP, AAS) |
| Free T3 | Free T3 | Spectroscopy (XRF, ICP, AAS) |
| Free T4 | Free T4 | Spectroscopy (XRF, ICP, AAS) |
| Glucose | Glucose | Spectroscopy (XRF, ICP, AAS) |
| HDL Cholesterol | HDL-Cholesterol | Spectroscopy (XRF, ICP, AAS) |
| Homocysteine | Homocysteine | Spectroscopy (XRF, ICP, AAS) |
| Iron | Iron | Spectroscopy (XRF, ICP, AAS) |
| Lithium | Lithium | Spectroscopy (XRF, ICP, AAS) |
| Magnesium | Magnesium | Spectroscopy (XRF, ICP, AAS) |
| Oestradiol | Oestradiol | Spectroscopy (XRF, ICP, AAS) |
| Pancreatic Elastase | Pancreatic Elastase | Spectroscopy (XRF, ICP, AAS) |
| Paracetamol | Paracetamol | Spectroscopy (XRF, ICP, AAS) |
| Plasminogen | Plasminogen | Spectroscopy (XRF, ICP, AAS) |
| Progesterone | Progesterone | Spectroscopy (XRF, ICP, AAS) |
| SHBG | SHBG | Spectroscopy (XRF, ICP, AAS) |
| TSH | TSH | Spectroscopy (XRF, ICP, AAS) |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.